
mskcc.org
Apr 26, 2025, 10:37
Elli Papaemmanuil: Tumor-Infiltrating Clonal Hematopoiesis
Elli Papaemmanuil, Co-Founder and CEO of Isabl and Associate Professor of Computational Oncology Service at MSKCC, shared a post on X by Eric Topol, Founder and Director of the Scripps Research Translational Institute, about a paper she co-authored with colleagues published in NEJM:
“Tumor-Infiltrating Clonal Hematopoiesis”
Authors: Oriol Pich, Elsa Bernard, Maria Zagorulya, Andrew Rowan, Constandina Pospori, Charles Rudin, Adam Mead, Dominique Bonnet, Elli Papaemmanuil, Charles Swanton et al.
“It has been unclear why cancer patients with CH have worse outcomes. Our work published in NEJM uncovers that Tumour-infiltrating CH (TI-CH) has a direct role in immune remodelling of the TME with implications for tumor progression and treatment response.”
Quoting Eric Topol’s post:
“New evidence today in NEJM that age-related clonal hematopoiesis (CHIP) has a driver role in evolution of solid cancers.”
More posts featuring Eric Topol.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 26, 2025, 10:37
Apr 26, 2025, 09:19
Apr 26, 2025, 08:02
Apr 26, 2025, 04:56
Apr 26, 2025, 00:17